![]() |
Breast Cancer |
Free Subscription
2 Am J Clin Pathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
HER2 fluorescence in situ hybridization groups 2-4 breast cancers classified as
positive after targeted recounts following equivocal (2+) immunohistochemistry.
Am J Clin Pathol. 2025;163:837-846.
PubMed
Abstract available
Clinicopathologic and molecular characterization of low-grade, early-stage, and
HER2-positive invasive breast carcinoma.
Am J Clin Pathol. 2025;163:854-865.
PubMed
Abstract available
National Variation in Implementation of Sentinel Lymph Node Biopsy for Clinically
Node-Positive Patients Undergoing Neoadjuvant Therapy.
Ann Surg Oncol. 2025;32:4874-4882.
PubMed
Abstract available
A Multi-institutional Study to Evaluate the Effectiveness and Safety of a Supine
MRI-Based Guidance System, the Breast Cancer Locator(TM), for Breast Conserving
Surgery in Patients with Nonpalpable Breast Cancer.
Ann Surg Oncol. 2025 Jun 6. doi: 10.1245/s10434-025-17513.
PubMed
Abstract available
Adjuvant Radiation vs Endocrine Therapy After Lumpectomy for Early-Stage Breast
Cancer in Older Women: Analysis of Real-World Survival Outcomes.
Ann Surg Oncol. 2025 Jun 6. doi: 10.1245/s10434-025-17532.
PubMed
Abstract available
ASO Visual Abstract: A Multi-institutional Analysis of Contralateral Axillary
Metastases-Advanced Local-Regional Disease Divergent from Stage IV Breast Cancer.
Ann Surg Oncol. 2025 Jun 3. doi: 10.1245/s10434-025-17563.
PubMed
Low Socioeconomic Status at the Patient and Institutional Level Impact
Achievement of Breast Cancer Quality Standards.
Ann Surg Oncol. 2025 Jun 2. doi: 10.1245/s10434-025-17529.
PubMed
Abstract available
ASO Author Reflections: Contralateral Axillary Lymph Node Metastasis of Breast
Cancer: Time to Re-evaluate Conventional Thinking.
Ann Surg Oncol. 2025 Jun 2. doi: 10.1245/s10434-025-17535.
PubMed
Letter to the Editor Regarding "Differential Effects of Endocrine Therapy Type on
Quality of Life in Older (>/= 70 Years) Women with Early-Stage Breast Cancer".
Ann Surg Oncol. 2025 May 31. doi: 10.1245/s10434-025-17593.
PubMed
Intraoperative Radiation Therapy (IORT) for Breast Cancer: The Final Analysis of
a Prospective Cohort of 1828 Cases.
Ann Surg Oncol. 2025 May 31. doi: 10.1245/s10434-025-17546.
PubMed
Abstract available
ASO Visual Abstract: Disparities in Timeliness of Breast Cancer Treatment in a
Rural Setting; Rural Breast Cancer Treatment Disparities.
Ann Surg Oncol. 2025 May 30. doi: 10.1245/s10434-025-17476.
PubMed
The Five-Item Modified Frailty Index Predicts Adverse Surgical Outcomes in
Patients Undergoing Mastectomy.
Ann Surg Oncol. 2025;32:4829-4837.
PubMed
Abstract available
Positive Margin Rates After Breast-Conserving Surgery by Histologic Subtype: A
Systematic Review and Meta-analysis Evaluating the Impact of Oncoplastic Surgery.
Ann Surg Oncol. 2025;32:4899-4909.
PubMed
Abstract available
Clinical and pharmacogenomic predictors of survival in tamoxifen treated breast
cancer female patients: a real-world study.
BMC Cancer. 2025;25:974.
PubMed
Abstract available
Self-reported side effects of breast cancer treatment and its impact on quality
of life: a multicenter cross-sectional study in a low- and middle-income country.
BMC Cancer. 2025;25:975.
PubMed
Abstract available
Multi-modal radiomics model based on four imaging modalities for predicting
pathological complete response to neoadjuvant treatment in breast cancer.
BMC Cancer. 2025;25:985.
PubMed
Abstract available
From biomarker to targeted therapy: investigating trophoblast cell-surface
antigen 2 expression in triple-negative breast cancer- insights from the national
cancer institute.
BMC Cancer. 2025;25:1008.
PubMed
Abstract available
Radiation therapy in clinically node positive HER2 positive breast cancer after
primary systemic therapy and breast conserving surgery: pooled analysis of
TRYPHAENA and NeoSphere trials.
BMC Cancer. 2025;25:996.
PubMed
Abstract available
The impact of sodium-glucose cotransporter-2 inhibitors on breast cancer and
cancer-related mortality: a systematic review and meta-analysis of randomized
controlled trials.
BMC Cancer. 2025;25:991.
PubMed
Abstract available
Breast cancer incidence in Indonesia: a sex-disaggregated analysis using WHO
health equity assessment toolkit data.
BMC Cancer. 2025;25:986.
PubMed
Abstract available
Clinical application of 90-gene expression test in a patient with occult breast
cancer: a case report and literature review.
Breast Cancer. 2025 Jun 5. doi: 10.1007/s12282-025-01728.
PubMed
Abstract available
Meta-analysis of smoking and breast cancer risk: by age of smoking initiation.
Breast Cancer. 2025 Jun 3. doi: 10.1007/s12282-025-01715.
PubMed
Abstract available
Breast Cancer (Dove Med Press)
CD151 Promotes Cancer Progression in Triple-Negative Breast Cancer by Inducing
EMT through the MAPK Signaling Pathway.
Breast Cancer (Dove Med Press). 2025;17:455-470.
PubMed
Abstract available
Aromatase inhibitors therapy and major osteoporotic fracture risk in
postmenopausal breast cancer patients: a nationwide real-world cohort study.
Breast Cancer Res. 2025;27:95.
PubMed
Abstract available
Advances in CTC and ctDNA detection techniques: opportunities for improving
breast cancer care.
Breast Cancer Res. 2025;27:97.
PubMed
Abstract available
Sialylated IgG expressed in triple-negative breast cancer cells promotes cancer
progression by promoting glycolysis.
Breast Cancer Res. 2025;27:96.
PubMed
Abstract available
Correction: Methylglyoxal, a glycolysis metabolite, triggers metastasis through
MEK/ERK/SMAD1 pathway activation in breast cancer.
Breast Cancer Res. 2025;27:99.
PubMed
SENP5 drives breast cancer progression through deSUMOYlation of CDK1.
Breast Cancer Res. 2025;27:100.
PubMed
Abstract available
Dissecting the tumor microenvironment in primary breast angiosarcoma: insights
from single-cell RNA sequencing.
Breast Cancer Res. 2025;27:101.
PubMed
Abstract available
Continuous glucose monitoring to characterize hyperglycemia during chemotherapy
for early stage breast cancer.
Breast Cancer Res Treat. 2025 Jun 4. doi: 10.1007/s10549-025-07745.
PubMed
Abstract available
A mixed-methods study characterizing experiences of medical oncologists' use of
gonadotropin-releasing hormone agonists for treatment of breast cancer.
Breast Cancer Res Treat. 2025 Jun 3. doi: 10.1007/s10549-025-07734.
PubMed
Abstract available
National trends in neoadjuvant systemic therapy utilization in patients with
early-stage HER2-positive breast cancer from 2016-2021: The impact of the
KATHERINE trial.
Breast Cancer Res Treat. 2025 Jun 3. doi: 10.1007/s10549-025-07750.
PubMed
Abstract available
Insurer and patient costs for repeat breast surgery after initial lumpectomy for
breast cancer.
Breast Cancer Res Treat. 2025 Jun 3. doi: 10.1007/s10549-025-07735.
PubMed
Abstract available
Breast imaging recommendations for young females (age < 40 years) with >/= 20%
lifetime breast cancer risk: practice patterns at a specialized clinic.
Breast Cancer Res Treat. 2025 Jun 1. doi: 10.1007/s10549-025-07738.
PubMed
Abstract available
Efficacy and safety of entinostat plus exemestane in hormone receptor-positive
breast cancer: a systematic review meta-analysis of randomized controlled trials.
Breast Cancer Res Treat. 2025 May 31. doi: 10.1007/s10549-025-07737.
PubMed
Abstract available
Utility of plasma circulating DNA tumor fraction in bone-only metastatic breast
cancer: a real-world outcomes study.
Breast Cancer Res Treat. 2025 May 30. doi: 10.1007/s10549-025-07740.
PubMed
Abstract available
Management of ipsilateral breast tumor recurrence after prior breast conservation
therapy.
Breast Cancer Res Treat. 2025;212:361-369.
PubMed
Abstract available
Invasive lobular breast carcinoma variants; clinicopathological features and
patient outcomes.
Breast Cancer Res Treat. 2025;212:347-359.
PubMed
Abstract available
Machine learning prediction of pathological complete response to neoadjuvant
chemotherapy with peritumoral breast tumor ultrasound radiomics: compare with
intratumoral radiomics and clinicopathologic predictors.
Breast Cancer Res Treat. 2025;212:325-336.
PubMed
Abstract available
Radiation recall dermatitis induced by abemaciclib with successful rechallenge: a
case series and literature review.
Breast Cancer Res Treat. 2025;212:189-193.
PubMed
Abstract available
Randomized trial of a community-based, culturally tailored intervention: High
engagement among Latina breast cancer survivors.
Cancer. 2025;131:e35842.
PubMed
Abstract available
Racial and ethnic variation in body composition and prognosis of nonmetastatic
breast cancer.
Cancer. 2025;131:e35926.
PubMed
Abstract available
Cancer Epidemiol Biomarkers Prev
Lifestyle and Breast Cancer Risk: How Does It All Add Up?
Cancer Epidemiol Biomarkers Prev. 2025;34:833-835.
PubMed
Abstract available
Human Immunodeficiency Virus-Associated Differences in the Tumor Immune
Microenvironment of Lung, Breast, and Prostate Cancers.
Cancer Epidemiol Biomarkers Prev. 2025;34:860-867.
PubMed
Abstract available
The Breast Tumor Immune Microenvironment of DNA Double-Strand Break Repair
Pathogenic Variant Carriers Is Enriched with Tumor-Associated Macrophages.
Cancer Epidemiol Biomarkers Prev. 2025;34:868-874.
PubMed
Abstract available
Improved Breast Cancer Detection with Artificial Intelligence in a Real-World
Digital Breast Tomosynthesis Screening Program.
Clin Breast Cancer. 2025 May 9:S1526-8209(25)00120.
PubMed
Abstract available
The Construction of a New Prognostic Model of Breast Cancer and the Exploration
of Drug Sensitivity Based on Machine Learning for Glycosylation-Related Genes.
Clin Breast Cancer. 2025 May 10:S1526-8209(25)00117.
PubMed
Abstract available
Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and
Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early
Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study.
Clin Breast Cancer. 2025 May 3:S1526-8209(25)00107.
PubMed
Abstract available
Ultrasound Radiomics-Based Machine Learning and SHapley Additive exPlanations
Method Predicting Pathological Prognostic Stage in Breast Cancer: A Bicentric and
Validation Study.
Clin Breast Cancer. 2025 May 8:S1526-8209(25)00114.
PubMed
Abstract available
[(18)F]FDG PET/MRI vs sentinel node biopsy for axillary staging of early breast
cancer patients. A prospective single-arm trial.
Eur J Cancer. 2025;224:115519.
PubMed
Abstract available
Olive oil consumption and risk of breast cancer: Prospective results from the
Moli-sani Study, and a systematic review of observational studies and randomized
clinical trials.
Eur J Cancer. 2025;224:115520.
PubMed
Abstract available
Additional breast lesions on MRI in patients with small early-stage luminal-type
breast cancer: Implications for future thermal ablation treatment.
Eur J Surg Oncol. 2025;51:110173.
PubMed
Intercostobrachial nerve preservation during breast cancer surgery to prevent
chronic postsurgical pain: A systematic review and meta-analysis of randomized
controlled trials.
Eur J Surg Oncol. 2025;51:110214.
PubMed
Abstract available
Metastatic breast cancer cells adapt to a soft environment with limited
involvement of mechanotransduction.
Exp Cell Res. 2025;450:114629.
PubMed
Abstract available
Retesting of oestrogen receptor, progesterone receptor and HER2 status of
invasive carcinoma of the breast after neoadjuvant chemotherapy.
Histopathology. 2025;87:58-67.
PubMed
Abstract available
Reply to: "Comments on the paper 'Extensive epigenomic dysregulation is a
hallmark of homologous recombination deficiency in triple-negative breast cancer'
by Y. Chen et al.".
Int J Cancer. 2025;157:590-591.
PubMed
Patient factors and modifications to intended chemotherapy for women with Stages
I-IIIA breast cancer.
Int J Cancer. 2025 Jun 2. doi: 10.1002/ijc.35494.
PubMed
Abstract available
Mass cytometric detection of homologous recombination proficiency in circulating
tumor cells to predict chemoresistance of metastatic breast cancer patients.
Int J Cancer. 2025 Jun 2. doi: 10.1002/ijc.35498.
PubMed
Abstract available
Comments on the paper "Extensive epigenomic dysregulation is a hallmark of
homologous recombination deficiency in triple-negative breast cancer" by Y. Chen
et al.
Int J Cancer. 2025;157:588-589.
PubMed
Multimodality Treatment De-Intensification in Node-Negative, Hormone-Receptor
Breast Cancer: What Are the Limits?
Int J Radiat Oncol Biol Phys. 2025 Jun 1:S0360-3016(25)00551.
PubMed
Abstract available
Melatonin-mediated cGAS-STING signal in senescent macrophages promote TNBC
chemotherapy resistance and drive the SASP.
J Biol Chem. 2025;301:108438.
PubMed
Abstract available
FGFR3-induced Y158 PARP1 phosphorylation promotes PARP-inhibitor resistance via
BRG1/MRE11-mediated DNA repair in breast cancer models.
J Clin Invest. 2025 May 29:e173757. doi: 10.1172/JCI173757.
PubMed
Abstract available
The class II myosin MYH4 safeguards genome integrity and suppresses tumor
progression.
J Clin Invest. 2025;135:e188165.
PubMed
Abstract available
Quantitative [(89)Zr]Zr-Trastuzumab PET and Diffusion- Weighted MRI for
Characterization of Metastatic HER2-Positive Breast Cancer with PET/MRI.
J Nucl Med. 2025 Jun 5:jnumed.124.268931. doi: 10.2967/jnumed.124.268931.
PubMed
Abstract available
(225)Ac alpha-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor
Receptor 2-Expressing Breast Cancer.
J Nucl Med. 2025 Jun 5:jnumed.125.269601. doi: 10.2967/jnumed.125.269601.
PubMed
Abstract available
Perioperative Venous Thromboembolism Chemoprophylaxis Does Not Increase Risk of
Complications in Free Flap Breast Reconstruction.
J Surg Oncol. 2025;131:1211-1221.
PubMed
Abstract available
Contemporary Trends in Reconstruction for Patients With Sarcoma of the Breast.
J Surg Oncol. 2025;131:1013-1023.
PubMed
Abstract available
Association of Socio-Environmental Burden and Inequality With Cancer Screening
and Mortality.
J Surg Oncol. 2025;131:1110-1117.
PubMed
Abstract available
Enhancing Patient Decision-Making in Breast Reconstruction: A Systematic Review
of Decision Aid Efficacy.
J Surg Oncol. 2025;131:1222-1235.
PubMed
Abstract available
Soluble sFas, sFasL, sPD1, and sPDL1 Analyses in the Peripheral Blood of Locally
Advanced Breast Cancer Patients Before and After Neoadjuvant Chemotherapy.
J Surg Oncol. 2025 Jun 2. doi: 10.1002/jso.27723.
PubMed
Abstract available
Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer.
N Engl J Med. 2025 Jun 2. doi: 10.1056/NEJMoa2415566.
PubMed
Abstract available
First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer.
N Engl J Med. 2025 Jun 1. doi: 10.1056/NEJMoa2502929.
PubMed
Abstract available
Overall Survival with Inavolisib in PIK3CA-Mutated Advanced Breast Cancer.
N Engl J Med. 2025 May 31. doi: 10.1056/NEJMoa2501796.
PubMed
Abstract available
Menopausal Symptom Management in Breast Cancer Survivors - A Promising New
Option.
N Engl J Med. 2025 Jun 2. doi: 10.1056/NEJMe2506475.
PubMed
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer.
N Engl J Med. 2025 May 31. doi: 10.1056/NEJMoa2505725.
PubMed
Abstract available
Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy.
N Engl J Med. 2025;392:2113-2124.
PubMed
Abstract available
Development and characterisation of a novel 3D in vitro model of
obesity-associated breast cancer as a tool for drug testing.
NPJ Breast Cancer. 2025;11:50.
PubMed
Abstract available
Genomic Landscape of Advanced Solid Tumors in Middle East and North Africa Using
Circulating Tumor DNA in Routine Clinical Practice.
Oncology. 2025;103:508-520.
PubMed
Abstract available
Understanding motivations of older women to continue or discontinue breast cancer
screening.
PLoS One. 2025;20:e0319141.
PubMed
Abstract available
Breast cancer screening practices during a multifaceted crisis: Data from
Lebanon.
PLoS One. 2025;20:e0325604.
PubMed
Abstract available
Aripiprazole use and lowering the risk of breast cancer in patient with
schizophrenia in a national cohort study.
PLoS One. 2025;20:e0324257.
PubMed
Gut microbiota and its influence on the Gut-Brain axis in comparison with
chemotherapy patients and cancer-free control data in Breast cancer-A
computational perspective.
PLoS One. 2025;20:e0324742.
PubMed
Abstract available
Intelligent and precise auxiliary diagnosis of breast tumors using deep learning
and radiomics.
PLoS One. 2025;20:e0320732.
PubMed
Abstract available
How should artificial intelligence be used in breast screening? Women's reasoning
about workflow options.
PLoS One. 2025;20:e0323528.
PubMed
Abstract available
Reshaping the landscape of locoregional treatments for breast cancer liver
metastases: A novel, intratumoral, p21-targeted percutaneous therapy increases
survival in BALB/c mice inoculated with 4T1 triple negative breast cancer cells
in the liver.
PLoS One. 2025;20:e0323621.
PubMed
Abstract available
Factors associated with breast lesions among women attending select teaching and
referral health facilities in Kenya: A cross-sectional study.
PLoS One. 2025;20:e0309182.
PubMed
Abstract available
Performance of Diagnostic Breast Imaging in Symptomatic Pregnant and Lactating
Patients: Systematic Review and Meta-Analysis.
Radiol Imaging Cancer. 2025;7:e240281.
PubMed
Abstract available
Rising Rates of Distant-Stage Breast Cancer: Trends Among U.S. Women.
Radiol Imaging Cancer. 2025;7:e259012.
PubMed
Impact of Method of Detection of Breast Cancer on Clinical Outcomes in
Individuals Aged 40 Years or Older.
Radiol Imaging Cancer. 2025;7:e240046.
PubMed
Abstract available
Adaptive Breast MRI Scanning Using AI.
Radiology. 2025;315:e242924.
PubMed
Abstract available
Thank you for your interest in scientific medicine.